These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38550926)

  • 1. UK biobank: Enhanced assessment of the epidemiology and long-term impact of coronavirus disease-2019.
    Feng Q; Lacey B; Bešević J; Omiyale W; Conroy M; Starkey F; Calvin C; Callen H; Bramley L; Welsh S; Young A; Effingham M; Young A; Collins R; Holliday J; Allen N
    Camb Prism Precis Med; 2023; 1():e30. PubMed ID: 38550926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank.
    Niedzwiedz CL; O'Donnell CA; Jani BD; Demou E; Ho FK; Celis-Morales C; Nicholl BI; Mair FS; Welsh P; Sattar N; Pell JP; Katikireddi SV
    BMC Med; 2020 May; 18(1):160. PubMed ID: 32466757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social determinants of ethnic disparities in SARS-CoV-2 infection: UK Biobank SARS-CoV-2 Serology Study.
    Omiyale W; Holliday J; Doherty N; Callen H; Wood N; Horn E; Burnett F; Young A; Lewington S; Fry D; Bešević J; Conroy M; Sheard S; Feng Q; Welsh S; Effingham M; Young A; Collins R; Lacey B; Allen N
    J Epidemiol Community Health; 2023 Dec; 78(1):3-10. PubMed ID: 37699665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic linkage of COVID-19 test results between Public Health England's Second Generation Surveillance System and UK Biobank.
    Armstrong J; Rudkin JK; Allen N; Crook DW; Wilson DJ; Wyllie DH; O'Connell AM
    Microb Genom; 2020 Jul; 6(7):. PubMed ID: 32553051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Rapid Online Surveys to Assess People's Perceptions During Infectious Disease Outbreaks: A Cross-sectional Survey on COVID-19.
    Geldsetzer P
    J Med Internet Res; 2020 Apr; 22(4):e18790. PubMed ID: 32240094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.
    Bešević J; Lacey B; Callen H; Omiyale W; Conroy M; Feng Q; Crook DW; Doherty N; Ebner D; Eyre DW; Fry D; Horn E; Jones EY; Marsden BD; Peto TEA; Starkey F; Stuart D; Welsh S; Wood N; Young A; Young A; Effingham M; Collins R; Holliday J; Allen N
    J Epidemiol Community Health; 2023 Nov; 78(2):105-8. PubMed ID: 37923370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
    Halford S; Wan S; Dragoni I; Silvester J; Nazarov B; Anthony D; Anthony S; Ladds E; Norrie J; Dhaliwal K;
    Trials; 2021 Aug; 22(1):550. PubMed ID: 34412682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study.
    Meredith LW; Hamilton WL; Warne B; Houldcroft CJ; Hosmillo M; Jahun AS; Curran MD; Parmar S; Caller LG; Caddy SL; Khokhar FA; Yakovleva A; Hall G; Feltwell T; Forrest S; Sridhar S; Weekes MP; Baker S; Brown N; Moore E; Popay A; Roddick I; Reacher M; Gouliouris T; Peacock SJ; Dougan G; Török ME; Goodfellow I
    Lancet Infect Dis; 2020 Nov; 20(11):1263-1272. PubMed ID: 32679081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of air pollution with COVID-19 positivity, hospitalisations, and mortality: Observational evidence from UK Biobank.
    Sheridan C; Klompmaker J; Cummins S; James P; Fecht D; Roscoe C
    Environ Pollut; 2022 Sep; 308():119686. PubMed ID: 35779662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 symptom surveillance in immunocompromised children and young people in the UK: a prospective observational cohort study.
    Shaunak M; Patel R; Driessens C; Mills L; Leahy A; Gbesemete D; Owens DR; Lucas JS; Faust SN; de Graaf H;
    BMJ Open; 2021 Mar; 11(3):e044899. PubMed ID: 33737439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
    Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
    Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occupational characteristics associated with SARS-CoV-2 infection in the UK Biobank during August-November 2020: a cohort study.
    Yanik EL; Evanoff BA; Dale AM; Ma Y; Walker-Bone KE
    BMC Public Health; 2022 Oct; 22(1):1884. PubMed ID: 36217157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank.
    Petermann-Rocha F; Hanlon P; Gray SR; Welsh P; Gill JMR; Foster H; Katikireddi SV; Lyall D; Mackay DF; O'Donnell CA; Sattar N; Nicholl BI; Pell JP; Jani BD; Ho FK; Mair FS; Celis-Morales C
    BMC Med; 2020 Nov; 18(1):355. PubMed ID: 33167965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort study.
    Molteni E; Canas LS; Kläser K; Deng J; Bhopal SS; Hughes RC; Chen L; Murray B; Kerfoot E; Antonelli M; Sudre CH; Pujol JC; Polidori L; May A; Hammers PA; Wolf J; Spector PTD; Steves CJ; Ourselin PS; Absoud M; Modat M; Duncan PEL
    Lancet Reg Health Eur; 2022 Aug; 19():100429. PubMed ID: 35821715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
    Hall VJ; Foulkes S; Charlett A; Atti A; Monk EJM; Simmons R; Wellington E; Cole MJ; Saei A; Oguti B; Munro K; Wallace S; Kirwan PD; Shrotri M; Vusirikala A; Rokadiya S; Kall M; Zambon M; Ramsay M; Brooks T; Brown CS; Chand MA; Hopkins S;
    Lancet; 2021 Apr; 397(10283):1459-1469. PubMed ID: 33844963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.